Sign inJoin waitlistJoin the waitlist

Nicholas Fidelman

Professor · University of California (San Francisco) School of Medicine

Credentials: · · ·

History

University of California (San Francisco) School of Medicine
Present

Interventional Radiology
University of California (San Francisco) School of Medicine
2007–2008
Diagnostic Radiology
University of California (San Francisco) School of Medicine
2003–2007
St. Mary's Medical Center
2002–2003
Univ of California, San Francisco Sch of Med
1998–2002

Research

Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria
Hepatology · 2015 · 378 citations
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma
Liver Transplantation · 2011 · 136 citations
Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy
Proceedings of the National Academy of Sciences of the United States of America · 2000 · 127 citations

RK
Robert Kerlan
50 papers
JL
Jean Laberge
29 papers
Maureen Kohi
28 papers
Andrew Taylor
22 papers · 12 as a fellow
Pallav Kolli
21 papers
Roy Gordon
19 papers
Francis Yao
12 papers
EL
Evan Lehrman
11 papers
Neil Mehta
10 papers · 2 as a fellow
Mark Wilson
9 papers · 2 as a resident
MH
Mikhail Higgins
9 papers
Ryan Kohlbrenner
9 papers · 4 as a resident

Clinical trials

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases
Principal investigator · Completed · Phase 2
Nicholas Fidelman, MD
2018–2026
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
Principal investigator · Completed · Phase 1
University of California, San Francisco
2017–2021
TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve
Principal investigator · Terminated
University of California, San Francisco
2014–2017
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Principal investigator · Terminated
University of California, San Francisco
2010–2014